Form 144: Insider sale of 7,800 shares reported
Issuer submitted a Form 144 disclosing proposed insider sales of Common stock and recent sales.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Issuer submitted a Form 144 disclosing proposed insider sales of Common stock and recent sales. The filing shows restricted shares listed with 03/15/2025 (4,249 and 1,145 shares) and 04/15/2025 (835 shares). It also records a sale by Maciej Kurzymski of 7,800 shares on 03/16/2026 for $1,184,437.02.
The filing date appears as 05/13/2026. The disclosure is a routine Section 16 resale notice reporting planned sales and a recent disposition; cash‑flow treatment and planned sale mechanics are not detailed in the provided excerpt.
Insights
Routine resale disclosure showing planned restricted‑share sales and a recent insider sale.
The excerpt lists restricted Common stock awards dated 03/15/2025 (4,249 and 1,145 shares) and 04/15/2025 (835 shares). It separately records a prior sale of 7,800 shares on 03/16/2026 for $1,184,437.02.
These items are typical Form 144 disclosures. Timing and distribution method for the proposed sales are not specified in the excerpt; subsequent filings or broker updates may provide execution details.
Key Figures
Key Terms
Restricted Stock financial
Form 144 regulatory
Securities To Be Sold regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 for BE disclose?
Which restricted stock grants are listed in the BE Form 144 excerpt?
Does the filing state when the proposed sales will occur?
What is the filing date shown in the excerpt for this Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.